Searched for
AUROBINDO PHARMA Q2 FY24 EARNINGS
NTPC power generation grows 13% to 118 bn units in Q2; coal dispatch up 28%NTPC has achieved a significant 13 percent year-on-year growth in power generation for the July-September quarter. The power generation inc...01 Oct, 2026, 03.49 PM IST- Tata Motors PV shares fall over 3% despite 40% Q2 sales growth; Nifty Auto index down over 4%Tata Motors Passenger Vehicles shares dipped on Thursday despite a 40% year-on-year rise in Q2 FY27 sales, while the Nifty Auto index decli...01 Oct, 2026, 02.27 PM IST
- RIL Q2 Results: Nuvama sees 17% EBITDA growth, led by O2C biz. Here’s what to expectReliance Industries is expected to report 17% year-on-year growth in Q2FY27 EBITDA to Rs 53,700 crore, led by stronger refining margins and...01 Oct, 2026, 01.23 PM IST
- ET Prime Special Series: Multibagger or IBC - Part 78: A tech company hiding inside an auto-parts maker. But with a weak spotThis is one of the most exciting businesses in the sector: A technology company disguised as an auto-parts maker, growing fast, earning exc...30 Sep, 2026, 08.38 PM IST
- Q2 earnings: Can India Inc repeat Q1, or will Q3 erase the base-effect tailwind?India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...30 Sep, 2026, 12.43 PM IST
- TCS, Wipro, other IT stocks rebound up to 6%, snapping 8-day losing streak. Why is Jefferies cautious?IT stocks rebounded on Wednesday, with TCS, Wipro and Coforge snapping an eight-session losing streak. The Nifty IT index rose nearly 3%, a...30 Sep, 2026, 11.51 AM IST
- Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s whyLenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA mar...30 Sep, 2026, 09.14 AM IST
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...29 Sep, 2026, 12.10 PM IST
- Nomura initiates coverage on Allied Blenders with Buy rating, sees up to 20% upsideNomura has initiated coverage on Allied Blenders & Distillers with a Buy rating and a target price of Rs 850, implying nearly 20% upside. T...29 Sep, 2026, 11.30 AM IST
- Honasa Consumer shares fall 5% after Rs 643 crore block deal; Peak XV, Sequoia likely sellersHonasa Consumer shares declined up to 5% after 1.4 crore shares worth Rs 643 crore changed hands in a block deal. The transaction comes aft...29 Sep, 2026, 10.15 AM IST
- Auto stocks: Festive demand gets a low-base boost; can earnings justify valuations?The Indian automobile market is witnessing robust retail sales as the festive season draws near. A significant year-on-year uptick of 81.8%...29 Sep, 2026, 09.50 AM IST
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...29 Sep, 2026, 08.56 AM IST
- Moneyview vs Orient Cables vs A-One Steels: Which IPO could give strong listing gains and long-term growth?Currently, three mainboard IPOs are capturing the interest of investors: Moneyview, Orient Cables, and A-One Steels. Each presents unique g...28 Sep, 2026, 03.54 PM IST
- Can Runwal Enterprises IPO deliver long-term growth for high-risk investors?In an effort to improve its financial health, Runwal Enterprises is set to raise ₹500 crore through a fresh issue primarily aimed at debt r...25 Sep, 2026, 06.41 AM IST
- ET Prime Special Series: Multibagger or IBC - Part 77: This auto ancillary wants to double revenue by FY30. Execution to decideA business can diversify in two ways: Slowly, by building new capabilities internally; or quickly, by acquisitions. This supplier has chose...23 Sep, 2026, 08.36 PM IST
- Meesho shares rally 12% after UBS hikes target price by 24%. What’s keeping analysts bullish?UBS has raised its Meesho estimates across NMV, contribution profit and EBITDA, citing stronger seller and buyer growth and improving unit ...22 Sep, 2026, 12.14 PM IST
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...16 Sep, 2026, 02.39 PM IST
Load More
